Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:associated_with |
risk of gastrointestinal bleeding
risk of liver damage rebound headaches |
| gptkbp:brand |
gptkb:Excedrin
|
| gptkbp:clinical_trial |
conducted for safety
conducted for efficacy |
| gptkbp:contains |
gptkb:acetaminophen
caffeine aspirin |
| gptkbp:countermeasures |
gptkb:theorem
|
| gptkbp:dosage_form |
oral
8 tablets in 24 hours 2 tablets every 6 hours |
| gptkbp:first_introduced |
1960s
|
| https://www.w3.org/2000/01/rdf-schema#label |
Excedrin
|
| gptkbp:ingredients |
gptkb:acetaminophen
caffeine aspirin |
| gptkbp:interacts_with |
gptkb:beer
blood thinners other NSAI Ds |
| gptkbp:is_available_in |
various formulations
|
| gptkbp:is_available_on |
gptkb:item
tablets caplets |
| gptkbp:is_used_for |
treatment of headaches
|
| gptkbp:manufacturer |
gptkb:Glaxo_Smith_Kline
|
| gptkbp:marketed_as |
fast relief
Excedrin Extra Strength Excedrin Migraine Excedrin Tension Headache effective for migraines effective for tension headaches |
| gptkbp:packaging |
bottles
blister packs |
| gptkbp:previous_name |
acetaminophen/aspirin/caffeine
|
| gptkbp:release_region |
gptkb:Australia
gptkb:India gptkb:United_Kingdom gptkb:United_States gptkb:Native_American_tribe |
| gptkbp:shelf_life |
2-3 years
|
| gptkbp:side_effect |
dizziness
nausea stomach upset |
| gptkbp:storage |
store at room temperature
keep away from moisture |
| gptkbp:suitable_for |
gptkb:hospital
adults pregnant women adolescents children under 12 people with certain medical conditions nursing mothers |
| gptkbp:bfsParent |
gptkb:Pfizer_Consumer_Healthcare
|
| gptkbp:bfsLayer |
4
|